V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20110317 | 20087212 | 1.7 | 66 | 03 | 2018-12-22 | 2019-01-21 | Capecitabine+Cisplatin+Streptozocin | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101063964 |
| 20110391 | 20087213 | 1.76 | 0 | Curative (C) | 2015-11-13 | 2015-11-27 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | ACTICCA-1 TRIAL | 100047149 |
| 20110422 | 20087214 | 1.5 | 50 | 03 | 2018-07-18 | 2018-07-27 | CHOP R - 21 days | 02 | N | CVD | 101057072 |
| 20110443 | 20087215 | 1.73 | 69.4 | Adjuvant (A) | 2018-12-03 | 2019-01-09 | Azacitidine | N | N | ESPAC TRIAL | 100044643 |
| 20110758 | 20087216 | null | null | 03 | 2020-12-03 | 2020-12-05 | null | 02 | N | RALTITREXED | 100838785 |
| 20111066 | 20087219 | 1.63 | 77.2 | null | 2020-02-17 | 2020-02-21 | Cisplatin + Fluorouracil + RT 5day | 99 | N | OXALIPLATIN | 101780473 |
| 20111083 | 20087220 | 1.78 | 90 | Adjuvant (A) | 2017-08-02 | 2017-08-16 | CETUXIMAB + RT | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101287389 |
| 20111191 | 20087222 | 1.66 | 104.2 | Palliative (P) | 2019-04-03 | 2019-04-09 | ACELARATE Trial | 02 | N | BACILLUS CALMETTE-GUERIN | 100997276 |
| 20111387 | 20087223 | 1.57 | 70.3 | Palliative (P) | 2018-10-14 | 2018-10-14 | null | 02 | N | NAB-PACLITAXEL | 101824299 |
| 20111420 | 20087224 | null | null | Palliative (P) | 2016-07-14 | 2016-08-03 | Hydroxycarbamide | 02 | N | OLAPARIB | 100714159 |
| 20111512 | 20087226 | null | null | 03 | 2016-08-03 | 2016-08-14 | Docetaxel | 02 | N | NIVOLUMAB | 101665359 |
| 20111607 | 20087228 | 1.64 | 67.3 | Palliative (P) | 2018-06-18 | 2018-07-13 | DOXORUBICIN + IFOSFAMIDE | 2 | N | GEMCITABINE + PACLITAXEL | 101695600 |
| 20111748 | 20087229 | null | null | 03 | 2020-01-12 | 2020-01-12 | PLATO Trials | 02 | null | PLATO TRIAL | 100504858 |
| 20111803 | 20087230 | 1.75 | 105.7 | 03 | null | 2018-05-22 | Rituximab | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100962586 |
| 20111997 | 20087231 | 1.79 | 56.1 | Adjuvant (A) | 2017-03-08 | 2017-03-15 | IPILIMUMAB + NIVOLUMAB | 02 | N | CARBO + FLUOROURACIL | 101189762 |
| 20112076 | 20087232 | 1.72 | 60.14 | Palliative (P) | 2019-04-09 | 2019-05-14 | IPILIMUMAB + NIVOLUMAB | null | N | CISPLATIN + FLUOROURACIL + RT | 101860498 |
| 20112199 | 20087233 | 1.72 | 56.05 | Palliative (P) | 2019-06-17 | 2019-06-21 | Capecitabine+Cisplatin+Streptozocin | 02 | N | CARBO + FLUOROURACIL | 101722338 |
| 20112277 | 20087235 | null | null | 03 | 2017-07-26 | 2017-07-26 | ECarboX | 99 | N | OXALIPLATIN | 100226272 |
| 20112298 | 20087236 | 1.53 | 63.4 | Palliative (P) | 2016-05-06 | 2016-05-07 | Paclitaxel albumin (Abraxane) 21day | 01 | N | ARISTOTLE TRIAL | 101600163 |
| 20112310 | 20087237 | 1.68 | 42.2 | Adjuvant (A) | 2016-08-24 | 2016-09-25 | SCOPE 2 TRIAL | null | N | CISPLATIN + VINORELBINE | 100275376 |
| 20112329 | 20087238 | 1.69 | 74 | null | 2018-07-09 | 2018-07-23 | OXALIPLATIN + MDG + PANITUMUMAB | 01 | N | CISPLATIN + FLUOROURACIL + RT | 101540728 |
| 20112393 | 20087239 | 1.53 | 58.8 | 03 | 2018-11-28 | 2018-12-07 | ESPAC-4 TRIAL | 02 | Y | FOXTROT TRIAL | 101254714 |
| 20112410 | 20087240 | 1.68 | 99 | Palliative (P) | 2021-04-30 | 2021-05-07 | Sunitinib | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101365980 |
| 20112418 | 20087241 | 1.81 | 15.4 | 03 | 2018-10-10 | 2018-10-24 | CAPE + OXALIPLATIN + TRASTUZUMAB | N | N | ESPAC TRIAL | 100309634 |
| 20112682 | 20087243 | 1.74 | 70.2 | Palliative (P) | 2017-02-15 | 2017-02-17 | Carboplatin + Pemetrexed | 02 | Y | CARBOPLATIN + FLUOROURACIL | 100909926 |
| 20112751 | 20087244 | 1.6 | 58 | Palliative (P) | 2018-04-29 | 2018-04-30 | Rituximab | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101260811 |
| 20112881 | 20087245 | null | 63 | Adjuvant (A) | 2018-05-15 | 2018-05-15 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 02 | N | CYCLOPHOSPHAMIDE | 101400442 |
| 20112919 | 20087246 | null | null | Palliative (P) | 2018-06-20 | 2018-06-27 | Ipilimumab | 02 | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101607604 |
| 20112936 | 20087247 | null | 75.6 | null | 2018-11-22 | 2018-11-23 | PACLITAXEL | 02 | N | NEO-AEGIS TRIAL | 101361935 |
| 20112947 | 20087248 | 0 | 104 | Palliative (P) | 2019-08-07 | 2019-08-08 | Bortezomib + MELPHALAN | 02 | N | MIC | 101334648 |
| 20112952 | 20087249 | 1.73 | 96 | Palliative (P) | 2018-06-23 | 2018-06-25 | FOXTROT TRIAL | 02 | N | ABIRATERONE | 101726390 |
| 20113008 | 20087250 | 1.81 | 68.2 | Palliative (P) | 2017-12-06 | 2017-12-14 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | RITUXIMAB | 100159269 |
| 20113049 | 20087251 | 1.61 | 95 | 03 | 2020-07-04 | 2020-07-30 | STREPTOZOCIN | 02 | N | ARISTOTLE TRIAL | 101853600 |
| 20113143 | 20087252 | 1.85 | 63.5 | Palliative (P) | null | 2018-09-15 | ACELARATE Trial | N | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101868970 |
| 20113162 | 20087253 | 1.57 | 92.65 | Palliative (P) | 2019-07-07 | 2019-07-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CISPLATIN + TEYSUNO | 100061610 |
| 20113237 | 20087255 | null | 43.6 | Palliative (P) | null | 2018-04-25 | Bevacizumab + Oxaliplatin +MdG | 01 | N | CARBOPLATIN + DOCETAXEL | 100150382 |
| 20113281 | 20087256 | 1.78 | 91.2 | null | null | 2020-01-04 | Paclitaxel 7 day | 02 | N | ECARBOX | 101332264 |
| 20113342 | 20087257 | 1.69 | 55.3 | Palliative (P) | 2016-04-27 | 2016-04-29 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | CISPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN | 101193866 |
| 20113382 | 20087258 | 1.59 | null | 03 | 2017-11-19 | 2017-12-01 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100486350 |
| 20113392 | 20087259 | null | 73.7 | null | 2017-04-02 | 2017-04-03 | FOXTROT TRIAL | 02 | N | CARBO + FLUOROURACIL | 101558808 |
| 20113405 | 20087260 | 1.6 | 61 | Palliative (P) | 2016-10-08 | 2016-10-08 | null | 01 | N | DACARBAZINE + DOXORUBICIN | 100152068 |
| 20113562 | 20087262 | 1.84 | 88.8 | 03 | 2016-10-16 | 2016-10-31 | Doxorubin 50mg/m2 | 2 | N | EVEROLIMUS | 100907376 |
| 20113617 | 20087263 | 1.76 | 51.5 | 03 | 2018-01-02 | 2018-01-02 | CARBOPLATIN + FLUOROURACIL | null | null | CARBOPLATIN + FLUOROURACIL | 100665505 |
| 20113933 | 20087264 | 1.48 | 52.65 | null | 2018-08-10 | 2018-08-12 | HEP SIOPEL 6 Cisplatin | 02 | N | RITUXIMAB | 101564671 |
| 20113996 | 20087265 | 1.7 | 81 | Palliative (P) | null | 2016-12-16 | OXALIPLATIN | 01 | N | EOF | 100148797 |
| 20114008 | 20087266 | 1.69 | 64.6 | Palliative (P) | 2019-06-24 | 2019-06-24 | DOXORUBICIN + IFOSFAMIDE | 02 | N | CHOP R | 101477786 |
| 20114120 | 20087267 | 1.58 | 74.2 | null | 2018-08-03 | 2018-08-03 | R-GEM-P | null | N | GEMCITABINE + PACLITAXEL | 101009875 |
| 20114244 | 20087268 | 1.67 | 80 | 03 | 2019-09-01 | 2019-09-11 | Hepatoblastoma HR Cisplatin | 99 | N | CISPLATIN + FLUOROURACIL + RT | 100551690 |
| 20114264 | 20087269 | 1.7 | 85.2 | Palliative (P) | 2019-08-08 | 2019-08-09 | Bevacizumab + Oxaliplatin +MdG | 02 | N | GEMCITABINE + OXALIPLATIN | 101026904 |
| 20114406 | 20087270 | null | null | 03 | 2017-11-01 | 2017-11-17 | Rituximab | 02 | N | CISPLATIN + RALTITREXED + TRASTUZUMAB | 101599390 |